Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Growth 2026-2032
The global Long-Acting Implant & Ocular Drug-Delivery Polymer System market size is predicted to grow from US$ 2512 million in 2025 to US$ 3973 million in 2032; it is expected to grow at a CAGR of 6.8% from 2026 to 2032.
A Long-Acting Implant & Ocular Drug-Delivery Polymer System is an advanced drug delivery platform that utilizes biodegradable or non-biodegradable polymer materials as carriers to provide sustained and controlled release of small molecules, biologics, or gene-based therapeutics directly to intraocular or periocular target sites. These systems are typically designed as implants, microspheres, microneedle-based depots, sustained-release films, or scaffolds capable of maintaining therapeutic drug concentrations for extended periods, thereby reducing the frequency of repeated intravitreal injections and improving patient adherence. Core technologies involve polymer degradation kinetics control, drug encapsulation efficiency, release profile modulation, biocompatibility optimization, and precision localization. This field represents a convergence of materials science, pharmaceutical engineering, and unmet clinical needs in ophthalmology. In 2025, global Long-Acting Implant & Ocular Drug-Delivery Polymer System production reached approximately 513.6 K Units and price is about 5000 USD/Unit. The average gross profit margin of this product is 55%.
Ophthalmic disease management is shifting from acute intervention to long-term chronic control, particularly in conditions such as age-related macular degeneration, diabetic retinopathy, and uveitis. The burden associated with frequent intravitreal injections has accelerated demand for sustained-release polymer systems capable of extending dosing intervals while maintaining therapeutic consistency. Advances in biodegradable polymers such as PLA, PLGA, and PCL, combined with the widespread adoption of biologics and anti-VEGF therapies, have reinforced the strategic importance of controlled release technologies. Regulatory acceptance of innovative delivery platforms further supports the establishment of differentiated product portfolios.
Key challenges include stringent biocompatibility requirements, lengthy safety validation processes, and complex clinical endpoints. Implant-based systems may present risks such as inflammatory responses or burst release, requiring highly controlled material purity and manufacturing consistency. Development costs are significant due to the dual demands of advanced materials engineering and sterile pharmaceutical production. Market penetration may also depend on physician training, procedural familiarity, and reimbursement policies for novel delivery approaches.
Clinical demand is evolving toward sustained therapeutic maintenance rather than repeated acute injections. Specialty ophthalmic centers and ambulatory surgical facilities increasingly favor solutions that reduce follow-up frequency and optimize clinical workflow efficiency. Patients prioritize safety and quality-of-life improvements. Future development trends point toward combination platforms integrating long-acting polymer systems with biologics, gene therapies, or anti-inflammatory agents to enable personalized, long-term treatment strategies.
Upstream inputs primarily include biodegradable polymers such as PLGA, PLA, and PCL, medical-grade silicone or polyurethane materials, high-purity solvents, crosslinking agents, and encapsulation excipients. Polymer molecular weight distribution and degradation kinetics directly influence release profile stability, necessitating stringent quality control and batch consistency. Sterile processing environments, precision molding, and microfabrication technologies are foundational capabilities. As smart-responsive and tunable degradation materials evolve, upstream suppliers with strong customization and collaborative innovation capacity are becoming increasingly strategic within the value chain.
LP Information, Inc. (LPI) ' newest research report, the “Long-Acting Implant & Ocular Drug-Delivery Polymer System Industry Forecast” looks at past sales and reviews total world Long-Acting Implant & Ocular Drug-Delivery Polymer System sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-Acting Implant & Ocular Drug-Delivery Polymer System sales for 2026 through 2032. With Long-Acting Implant & Ocular Drug-Delivery Polymer System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-Acting Implant & Ocular Drug-Delivery Polymer System industry.
This Insight Report provides a comprehensive analysis of the global Long-Acting Implant & Ocular Drug-Delivery Polymer System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Long-Acting Implant & Ocular Drug-Delivery Polymer System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-Acting Implant & Ocular Drug-Delivery Polymer System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-Acting Implant & Ocular Drug-Delivery Polymer System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-Acting Implant & Ocular Drug-Delivery Polymer System.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-Acting Implant & Ocular Drug-Delivery Polymer System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Long-Acting Implant & Ocular Drug-Delivery Polymer System market?
What factors are driving Long-Acting Implant & Ocular Drug-Delivery Polymer System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Long-Acting Implant & Ocular Drug-Delivery Polymer System market opportunities vary by end market size?
How does Long-Acting Implant & Ocular Drug-Delivery Polymer System break out by Type, by Application?
A Long-Acting Implant & Ocular Drug-Delivery Polymer System is an advanced drug delivery platform that utilizes biodegradable or non-biodegradable polymer materials as carriers to provide sustained and controlled release of small molecules, biologics, or gene-based therapeutics directly to intraocular or periocular target sites. These systems are typically designed as implants, microspheres, microneedle-based depots, sustained-release films, or scaffolds capable of maintaining therapeutic drug concentrations for extended periods, thereby reducing the frequency of repeated intravitreal injections and improving patient adherence. Core technologies involve polymer degradation kinetics control, drug encapsulation efficiency, release profile modulation, biocompatibility optimization, and precision localization. This field represents a convergence of materials science, pharmaceutical engineering, and unmet clinical needs in ophthalmology. In 2025, global Long-Acting Implant & Ocular Drug-Delivery Polymer System production reached approximately 513.6 K Units and price is about 5000 USD/Unit. The average gross profit margin of this product is 55%.
Ophthalmic disease management is shifting from acute intervention to long-term chronic control, particularly in conditions such as age-related macular degeneration, diabetic retinopathy, and uveitis. The burden associated with frequent intravitreal injections has accelerated demand for sustained-release polymer systems capable of extending dosing intervals while maintaining therapeutic consistency. Advances in biodegradable polymers such as PLA, PLGA, and PCL, combined with the widespread adoption of biologics and anti-VEGF therapies, have reinforced the strategic importance of controlled release technologies. Regulatory acceptance of innovative delivery platforms further supports the establishment of differentiated product portfolios.
Key challenges include stringent biocompatibility requirements, lengthy safety validation processes, and complex clinical endpoints. Implant-based systems may present risks such as inflammatory responses or burst release, requiring highly controlled material purity and manufacturing consistency. Development costs are significant due to the dual demands of advanced materials engineering and sterile pharmaceutical production. Market penetration may also depend on physician training, procedural familiarity, and reimbursement policies for novel delivery approaches.
Clinical demand is evolving toward sustained therapeutic maintenance rather than repeated acute injections. Specialty ophthalmic centers and ambulatory surgical facilities increasingly favor solutions that reduce follow-up frequency and optimize clinical workflow efficiency. Patients prioritize safety and quality-of-life improvements. Future development trends point toward combination platforms integrating long-acting polymer systems with biologics, gene therapies, or anti-inflammatory agents to enable personalized, long-term treatment strategies.
Upstream inputs primarily include biodegradable polymers such as PLGA, PLA, and PCL, medical-grade silicone or polyurethane materials, high-purity solvents, crosslinking agents, and encapsulation excipients. Polymer molecular weight distribution and degradation kinetics directly influence release profile stability, necessitating stringent quality control and batch consistency. Sterile processing environments, precision molding, and microfabrication technologies are foundational capabilities. As smart-responsive and tunable degradation materials evolve, upstream suppliers with strong customization and collaborative innovation capacity are becoming increasingly strategic within the value chain.
LP Information, Inc. (LPI) ' newest research report, the “Long-Acting Implant & Ocular Drug-Delivery Polymer System Industry Forecast” looks at past sales and reviews total world Long-Acting Implant & Ocular Drug-Delivery Polymer System sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-Acting Implant & Ocular Drug-Delivery Polymer System sales for 2026 through 2032. With Long-Acting Implant & Ocular Drug-Delivery Polymer System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-Acting Implant & Ocular Drug-Delivery Polymer System industry.
This Insight Report provides a comprehensive analysis of the global Long-Acting Implant & Ocular Drug-Delivery Polymer System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Long-Acting Implant & Ocular Drug-Delivery Polymer System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-Acting Implant & Ocular Drug-Delivery Polymer System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-Acting Implant & Ocular Drug-Delivery Polymer System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-Acting Implant & Ocular Drug-Delivery Polymer System.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-Acting Implant & Ocular Drug-Delivery Polymer System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Subcutaneous and Intramuscular Implants
- Intravitreal and Ocular Implants
- Oncology and Chronic Pain
- Ophthalmology
- Endocrine and Women's Health
- Other
- Biodegradable
- Non-Degradable
- Hospital
- Dental Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Alcon
- Johnson & Johnson
- Bausch + Lomb
- EyePoint Pharmaceuticals
- Regeneron Pharmaceuticals
- Santen Pharmaceutical
- Allergan (AbbVie)
- Alimera Sciences
- Ocular Therapeutix
- Graybug Vision
- Aerie Pharmaceuticals
- Neurotech Pharmaceuticals
- Teva Pharmaceutical Industries
- Sun Pharmaceutical Industries
- EyeGate Pharmaceuticals
- PolyActiva
- EyeD Pharma
- Ripple Therapeutics
- Re?Vana Therapeutics
What is the 10-year outlook for the global Long-Acting Implant & Ocular Drug-Delivery Polymer System market?
What factors are driving Long-Acting Implant & Ocular Drug-Delivery Polymer System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Long-Acting Implant & Ocular Drug-Delivery Polymer System market opportunities vary by end market size?
How does Long-Acting Implant & Ocular Drug-Delivery Polymer System break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Long-Acting Implant & Ocular Drug-Delivery Polymer System by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Long-Acting Implant & Ocular Drug-Delivery Polymer System by Country/Region, 2021, 2025 & 2032
2.2 Long-Acting Implant & Ocular Drug-Delivery Polymer System Segment by Type
2.2.1 Subcutaneous and Intramuscular Implants
2.2.2 Intravitreal and Ocular Implants
2.2.3 Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type
2.2.3.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Type (2021-2026)
2.2.3.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Type (2021-2026)
2.3 Long-Acting Implant & Ocular Drug-Delivery Polymer System Segment by Disease
2.3.1 Oncology and Chronic Pain
2.3.2 Ophthalmology
2.3.3 Endocrine and Women's Health
2.3.4 Other
2.3.5 Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Disease
2.3.5.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Disease (2021-2026)
2.3.5.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue and Market Share by Disease (2021-2026)
2.3.5.3 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Disease (2021-2026)
2.4 Long-Acting Implant & Ocular Drug-Delivery Polymer System Segment by Polymer Type
2.4.1 Biodegradable
2.4.2 Non-Degradable
2.4.3 Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Polymer Type
2.4.3.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Polymer Type (2021-2026)
2.4.3.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue and Market Share by Polymer Type (2021-2026)
2.4.3.3 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Polymer Type (2021-2026)
2.5 Long-Acting Implant & Ocular Drug-Delivery Polymer System Segment by Application
2.5.1 Hospital
2.5.2 Dental Clinic
2.5.3 Other
2.5.4 Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Application
2.5.4.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Market Share by Application (2021-2026)
2.5.4.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Breakdown Data by Company
3.1.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Sales by Company (2021-2026)
3.1.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Company (2021-2026)
3.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Revenue by Company (2021-2026)
3.2.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Company (2021-2026)
3.2.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Company (2021-2026)
3.3 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Company
3.4 Key Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Location Distribution
3.4.2 Players Long-Acting Implant & Ocular Drug-Delivery Polymer System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LONG-ACTING IMPLANT & OCULAR DRUG-DELIVERY POLYMER SYSTEM BY GEOGRAPHIC REGION
4.1 World Historic Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Size by Geographic Region (2021-2026)
4.1.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Size by Country/Region (2021-2026)
4.2.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Sales by Country/Region (2021-2026)
4.2.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Growth
4.4 APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Growth
4.5 Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Growth
4.6 Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Growth
5 AMERICAS
5.1 Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Country
5.1.1 Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Country (2021-2026)
5.1.2 Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Country (2021-2026)
5.2 Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type (2021-2026)
5.3 Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Region
6.1.1 APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Region (2021-2026)
6.1.2 APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Region (2021-2026)
6.2 APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type (2021-2026)
6.3 APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System by Country
7.1.1 Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Country (2021-2026)
7.1.2 Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Country (2021-2026)
7.2 Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type (2021-2026)
7.3 Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System by Country
8.1.1 Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Country (2021-2026)
8.1.2 Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Country (2021-2026)
8.2 Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type (2021-2026)
8.3 Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-Acting Implant & Ocular Drug-Delivery Polymer System
10.3 Manufacturing Process Analysis of Long-Acting Implant & Ocular Drug-Delivery Polymer System
10.4 Industry Chain Structure of Long-Acting Implant & Ocular Drug-Delivery Polymer System
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-Acting Implant & Ocular Drug-Delivery Polymer System Distributors
11.3 Long-Acting Implant & Ocular Drug-Delivery Polymer System Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING IMPLANT & OCULAR DRUG-DELIVERY POLYMER SYSTEM BY GEOGRAPHIC REGION
12.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Size Forecast by Region
12.1.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Forecast by Region (2027-2032)
12.1.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Forecast by Type (2027-2032)
12.7 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.1.3 Novartis Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Alcon
13.2.1 Alcon Company Information
13.2.2 Alcon Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.2.3 Alcon Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Alcon Main Business Overview
13.2.5 Alcon Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.3.3 Johnson & Johnson Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Bausch + Lomb
13.4.1 Bausch + Lomb Company Information
13.4.2 Bausch + Lomb Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.4.3 Bausch + Lomb Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bausch + Lomb Main Business Overview
13.4.5 Bausch + Lomb Latest Developments
13.5 EyePoint Pharmaceuticals
13.5.1 EyePoint Pharmaceuticals Company Information
13.5.2 EyePoint Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.5.3 EyePoint Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 EyePoint Pharmaceuticals Main Business Overview
13.5.5 EyePoint Pharmaceuticals Latest Developments
13.6 Regeneron Pharmaceuticals
13.6.1 Regeneron Pharmaceuticals Company Information
13.6.2 Regeneron Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.6.3 Regeneron Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Regeneron Pharmaceuticals Main Business Overview
13.6.5 Regeneron Pharmaceuticals Latest Developments
13.7 Santen Pharmaceutical
13.7.1 Santen Pharmaceutical Company Information
13.7.2 Santen Pharmaceutical Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.7.3 Santen Pharmaceutical Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Santen Pharmaceutical Main Business Overview
13.7.5 Santen Pharmaceutical Latest Developments
13.8 Allergan (AbbVie)
13.8.1 Allergan (AbbVie) Company Information
13.8.2 Allergan (AbbVie) Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.8.3 Allergan (AbbVie) Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Allergan (AbbVie) Main Business Overview
13.8.5 Allergan (AbbVie) Latest Developments
13.9 Alimera Sciences
13.9.1 Alimera Sciences Company Information
13.9.2 Alimera Sciences Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.9.3 Alimera Sciences Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Alimera Sciences Main Business Overview
13.9.5 Alimera Sciences Latest Developments
13.10 Ocular Therapeutix
13.10.1 Ocular Therapeutix Company Information
13.10.2 Ocular Therapeutix Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.10.3 Ocular Therapeutix Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Ocular Therapeutix Main Business Overview
13.10.5 Ocular Therapeutix Latest Developments
13.11 Graybug Vision
13.11.1 Graybug Vision Company Information
13.11.2 Graybug Vision Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.11.3 Graybug Vision Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Graybug Vision Main Business Overview
13.11.5 Graybug Vision Latest Developments
13.12 Aerie Pharmaceuticals
13.12.1 Aerie Pharmaceuticals Company Information
13.12.2 Aerie Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.12.3 Aerie Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Aerie Pharmaceuticals Main Business Overview
13.12.5 Aerie Pharmaceuticals Latest Developments
13.13 Neurotech Pharmaceuticals
13.13.1 Neurotech Pharmaceuticals Company Information
13.13.2 Neurotech Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.13.3 Neurotech Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Neurotech Pharmaceuticals Main Business Overview
13.13.5 Neurotech Pharmaceuticals Latest Developments
13.14 Teva Pharmaceutical Industries
13.14.1 Teva Pharmaceutical Industries Company Information
13.14.2 Teva Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.14.3 Teva Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Teva Pharmaceutical Industries Main Business Overview
13.14.5 Teva Pharmaceutical Industries Latest Developments
13.15 Sun Pharmaceutical Industries
13.15.1 Sun Pharmaceutical Industries Company Information
13.15.2 Sun Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.15.3 Sun Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Sun Pharmaceutical Industries Main Business Overview
13.15.5 Sun Pharmaceutical Industries Latest Developments
13.16 EyeGate Pharmaceuticals
13.16.1 EyeGate Pharmaceuticals Company Information
13.16.2 EyeGate Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.16.3 EyeGate Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 EyeGate Pharmaceuticals Main Business Overview
13.16.5 EyeGate Pharmaceuticals Latest Developments
13.17 PolyActiva
13.17.1 PolyActiva Company Information
13.17.2 PolyActiva Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.17.3 PolyActiva Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 PolyActiva Main Business Overview
13.17.5 PolyActiva Latest Developments
13.18 EyeD Pharma
13.18.1 EyeD Pharma Company Information
13.18.2 EyeD Pharma Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.18.3 EyeD Pharma Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 EyeD Pharma Main Business Overview
13.18.5 EyeD Pharma Latest Developments
13.19 Ripple Therapeutics
13.19.1 Ripple Therapeutics Company Information
13.19.2 Ripple Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.19.3 Ripple Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Ripple Therapeutics Main Business Overview
13.19.5 Ripple Therapeutics Latest Developments
13.20 Re?Vana Therapeutics
13.20.1 Re?Vana Therapeutics Company Information
13.20.2 Re?Vana Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.20.3 Re?Vana Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Re?Vana Therapeutics Main Business Overview
13.20.5 Re?Vana Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Long-Acting Implant & Ocular Drug-Delivery Polymer System by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Long-Acting Implant & Ocular Drug-Delivery Polymer System by Country/Region, 2021, 2025 & 2032
2.2 Long-Acting Implant & Ocular Drug-Delivery Polymer System Segment by Type
2.2.1 Subcutaneous and Intramuscular Implants
2.2.2 Intravitreal and Ocular Implants
2.2.3 Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type
2.2.3.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Type (2021-2026)
2.2.3.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Type (2021-2026)
2.3 Long-Acting Implant & Ocular Drug-Delivery Polymer System Segment by Disease
2.3.1 Oncology and Chronic Pain
2.3.2 Ophthalmology
2.3.3 Endocrine and Women's Health
2.3.4 Other
2.3.5 Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Disease
2.3.5.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Disease (2021-2026)
2.3.5.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue and Market Share by Disease (2021-2026)
2.3.5.3 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Disease (2021-2026)
2.4 Long-Acting Implant & Ocular Drug-Delivery Polymer System Segment by Polymer Type
2.4.1 Biodegradable
2.4.2 Non-Degradable
2.4.3 Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Polymer Type
2.4.3.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Polymer Type (2021-2026)
2.4.3.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue and Market Share by Polymer Type (2021-2026)
2.4.3.3 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Polymer Type (2021-2026)
2.5 Long-Acting Implant & Ocular Drug-Delivery Polymer System Segment by Application
2.5.1 Hospital
2.5.2 Dental Clinic
2.5.3 Other
2.5.4 Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Application
2.5.4.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Market Share by Application (2021-2026)
2.5.4.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Breakdown Data by Company
3.1.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Sales by Company (2021-2026)
3.1.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Company (2021-2026)
3.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Revenue by Company (2021-2026)
3.2.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Company (2021-2026)
3.2.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Company (2021-2026)
3.3 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Company
3.4 Key Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Location Distribution
3.4.2 Players Long-Acting Implant & Ocular Drug-Delivery Polymer System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LONG-ACTING IMPLANT & OCULAR DRUG-DELIVERY POLYMER SYSTEM BY GEOGRAPHIC REGION
4.1 World Historic Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Size by Geographic Region (2021-2026)
4.1.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Size by Country/Region (2021-2026)
4.2.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Sales by Country/Region (2021-2026)
4.2.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Growth
4.4 APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Growth
4.5 Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Growth
4.6 Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Growth
5 AMERICAS
5.1 Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Country
5.1.1 Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Country (2021-2026)
5.1.2 Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Country (2021-2026)
5.2 Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type (2021-2026)
5.3 Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Region
6.1.1 APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Region (2021-2026)
6.1.2 APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Region (2021-2026)
6.2 APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type (2021-2026)
6.3 APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System by Country
7.1.1 Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Country (2021-2026)
7.1.2 Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Country (2021-2026)
7.2 Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type (2021-2026)
7.3 Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System by Country
8.1.1 Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Country (2021-2026)
8.1.2 Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Country (2021-2026)
8.2 Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type (2021-2026)
8.3 Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-Acting Implant & Ocular Drug-Delivery Polymer System
10.3 Manufacturing Process Analysis of Long-Acting Implant & Ocular Drug-Delivery Polymer System
10.4 Industry Chain Structure of Long-Acting Implant & Ocular Drug-Delivery Polymer System
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-Acting Implant & Ocular Drug-Delivery Polymer System Distributors
11.3 Long-Acting Implant & Ocular Drug-Delivery Polymer System Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING IMPLANT & OCULAR DRUG-DELIVERY POLYMER SYSTEM BY GEOGRAPHIC REGION
12.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Market Size Forecast by Region
12.1.1 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Forecast by Region (2027-2032)
12.1.2 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Forecast by Type (2027-2032)
12.7 Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.1.3 Novartis Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Alcon
13.2.1 Alcon Company Information
13.2.2 Alcon Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.2.3 Alcon Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Alcon Main Business Overview
13.2.5 Alcon Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.3.3 Johnson & Johnson Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Bausch + Lomb
13.4.1 Bausch + Lomb Company Information
13.4.2 Bausch + Lomb Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.4.3 Bausch + Lomb Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Bausch + Lomb Main Business Overview
13.4.5 Bausch + Lomb Latest Developments
13.5 EyePoint Pharmaceuticals
13.5.1 EyePoint Pharmaceuticals Company Information
13.5.2 EyePoint Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.5.3 EyePoint Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 EyePoint Pharmaceuticals Main Business Overview
13.5.5 EyePoint Pharmaceuticals Latest Developments
13.6 Regeneron Pharmaceuticals
13.6.1 Regeneron Pharmaceuticals Company Information
13.6.2 Regeneron Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.6.3 Regeneron Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Regeneron Pharmaceuticals Main Business Overview
13.6.5 Regeneron Pharmaceuticals Latest Developments
13.7 Santen Pharmaceutical
13.7.1 Santen Pharmaceutical Company Information
13.7.2 Santen Pharmaceutical Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.7.3 Santen Pharmaceutical Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Santen Pharmaceutical Main Business Overview
13.7.5 Santen Pharmaceutical Latest Developments
13.8 Allergan (AbbVie)
13.8.1 Allergan (AbbVie) Company Information
13.8.2 Allergan (AbbVie) Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.8.3 Allergan (AbbVie) Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Allergan (AbbVie) Main Business Overview
13.8.5 Allergan (AbbVie) Latest Developments
13.9 Alimera Sciences
13.9.1 Alimera Sciences Company Information
13.9.2 Alimera Sciences Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.9.3 Alimera Sciences Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Alimera Sciences Main Business Overview
13.9.5 Alimera Sciences Latest Developments
13.10 Ocular Therapeutix
13.10.1 Ocular Therapeutix Company Information
13.10.2 Ocular Therapeutix Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.10.3 Ocular Therapeutix Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Ocular Therapeutix Main Business Overview
13.10.5 Ocular Therapeutix Latest Developments
13.11 Graybug Vision
13.11.1 Graybug Vision Company Information
13.11.2 Graybug Vision Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.11.3 Graybug Vision Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Graybug Vision Main Business Overview
13.11.5 Graybug Vision Latest Developments
13.12 Aerie Pharmaceuticals
13.12.1 Aerie Pharmaceuticals Company Information
13.12.2 Aerie Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.12.3 Aerie Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Aerie Pharmaceuticals Main Business Overview
13.12.5 Aerie Pharmaceuticals Latest Developments
13.13 Neurotech Pharmaceuticals
13.13.1 Neurotech Pharmaceuticals Company Information
13.13.2 Neurotech Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.13.3 Neurotech Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Neurotech Pharmaceuticals Main Business Overview
13.13.5 Neurotech Pharmaceuticals Latest Developments
13.14 Teva Pharmaceutical Industries
13.14.1 Teva Pharmaceutical Industries Company Information
13.14.2 Teva Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.14.3 Teva Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Teva Pharmaceutical Industries Main Business Overview
13.14.5 Teva Pharmaceutical Industries Latest Developments
13.15 Sun Pharmaceutical Industries
13.15.1 Sun Pharmaceutical Industries Company Information
13.15.2 Sun Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.15.3 Sun Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Sun Pharmaceutical Industries Main Business Overview
13.15.5 Sun Pharmaceutical Industries Latest Developments
13.16 EyeGate Pharmaceuticals
13.16.1 EyeGate Pharmaceuticals Company Information
13.16.2 EyeGate Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.16.3 EyeGate Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 EyeGate Pharmaceuticals Main Business Overview
13.16.5 EyeGate Pharmaceuticals Latest Developments
13.17 PolyActiva
13.17.1 PolyActiva Company Information
13.17.2 PolyActiva Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.17.3 PolyActiva Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 PolyActiva Main Business Overview
13.17.5 PolyActiva Latest Developments
13.18 EyeD Pharma
13.18.1 EyeD Pharma Company Information
13.18.2 EyeD Pharma Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.18.3 EyeD Pharma Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 EyeD Pharma Main Business Overview
13.18.5 EyeD Pharma Latest Developments
13.19 Ripple Therapeutics
13.19.1 Ripple Therapeutics Company Information
13.19.2 Ripple Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.19.3 Ripple Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Ripple Therapeutics Main Business Overview
13.19.5 Ripple Therapeutics Latest Developments
13.20 Re?Vana Therapeutics
13.20.1 Re?Vana Therapeutics Company Information
13.20.2 Re?Vana Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
13.20.3 Re?Vana Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Re?Vana Therapeutics Main Business Overview
13.20.5 Re?Vana Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Subcutaneous and Intramuscular Implants
Table 4. Major Players of Intravitreal and Ocular Implants
Table 5. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type (2021-2026) & (K Units)
Table 6. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Type (2021-2026)
Table 7. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Type (2021-2026) & ($ million)
Table 8. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Type (2021-2026)
Table 9. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Oncology and Chronic Pain
Table 11. Major Players of Ophthalmology
Table 12. Major Players of Endocrine and Women's Health
Table 13. Major Players of Other
Table 14. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Disease (2021-2026) & (K Units)
Table 15. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Disease (2021-2026)
Table 16. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Disease (2021-2026) & ($ million)
Table 17. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Disease (2021-2026)
Table 18. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Disease (2021-2026) & (US$/Unit)
Table 19. Major Players of Biodegradable
Table 20. Major Players of Non-Degradable
Table 21. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Polymer Type (2021-2026) & (K Units)
Table 22. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Polymer Type (2021-2026)
Table 23. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Polymer Type (2021-2026) & ($ million)
Table 24. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Polymer Type (2021-2026)
Table 25. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Polymer Type (2021-2026) & (US$/Unit)
Table 26. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale by Application (2021-2026) & (K Units)
Table 27. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Market Share by Application (2021-2026)
Table 28. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Application (2021-2026) & ($ million)
Table 29. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Application (2021-2026)
Table 30. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Company (2021-2026) & (K Units)
Table 32. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Company (2021-2026)
Table 33. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Company (2021-2026)
Table 35. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Producing Area Distribution and Sales Area
Table 37. Players Long-Acting Implant & Ocular Drug-Delivery Polymer System Products Offered
Table 38. Long-Acting Implant & Ocular Drug-Delivery Polymer System Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share Geographic Region (2021-2026)
Table 43. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Country/Region (2021-2026)
Table 47. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Country (2021-2026) & (K Units)
Table 50. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Country (2021-2026)
Table 51. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type (2021-2026) & (K Units)
Table 53. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Application (2021-2026) & (K Units)
Table 54. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Region (2021-2026) & (K Units)
Table 55. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Region (2021-2026)
Table 56. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type (2021-2026) & (K Units)
Table 58. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Application (2021-2026) & (K Units)
Table 59. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Country (2021-2026) & (K Units)
Table 60. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type (2021-2026) & (K Units)
Table 62. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Long-Acting Implant & Ocular Drug-Delivery Polymer System
Table 68. Key Market Challenges & Risks of Long-Acting Implant & Ocular Drug-Delivery Polymer System
Table 69. Key Industry Trends of Long-Acting Implant & Ocular Drug-Delivery Polymer System
Table 70. Long-Acting Implant & Ocular Drug-Delivery Polymer System Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Long-Acting Implant & Ocular Drug-Delivery Polymer System Distributors List
Table 73. Long-Acting Implant & Ocular Drug-Delivery Polymer System Customer List
Table 74. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Novartis Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 90. Novartis Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Alcon Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 94. Alcon Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 95. Alcon Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Alcon Main Business
Table 97. Alcon Latest Developments
Table 98. Johnson & Johnson Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 99. Johnson & Johnson Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 100. Johnson & Johnson Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Johnson & Johnson Main Business
Table 102. Johnson & Johnson Latest Developments
Table 103. Bausch + Lomb Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 104. Bausch + Lomb Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 105. Bausch + Lomb Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Bausch + Lomb Main Business
Table 107. Bausch + Lomb Latest Developments
Table 108. EyePoint Pharmaceuticals Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 109. EyePoint Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 110. EyePoint Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. EyePoint Pharmaceuticals Main Business
Table 112. EyePoint Pharmaceuticals Latest Developments
Table 113. Regeneron Pharmaceuticals Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 114. Regeneron Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 115. Regeneron Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Regeneron Pharmaceuticals Main Business
Table 117. Regeneron Pharmaceuticals Latest Developments
Table 118. Santen Pharmaceutical Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 119. Santen Pharmaceutical Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 120. Santen Pharmaceutical Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Santen Pharmaceutical Main Business
Table 122. Santen Pharmaceutical Latest Developments
Table 123. Allergan (AbbVie) Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 124. Allergan (AbbVie) Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 125. Allergan (AbbVie) Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Allergan (AbbVie) Main Business
Table 127. Allergan (AbbVie) Latest Developments
Table 128. Alimera Sciences Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 129. Alimera Sciences Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 130. Alimera Sciences Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Alimera Sciences Main Business
Table 132. Alimera Sciences Latest Developments
Table 133. Ocular Therapeutix Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 134. Ocular Therapeutix Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 135. Ocular Therapeutix Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Ocular Therapeutix Main Business
Table 137. Ocular Therapeutix Latest Developments
Table 138. Graybug Vision Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 139. Graybug Vision Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 140. Graybug Vision Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Graybug Vision Main Business
Table 142. Graybug Vision Latest Developments
Table 143. Aerie Pharmaceuticals Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 144. Aerie Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 145. Aerie Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. Aerie Pharmaceuticals Main Business
Table 147. Aerie Pharmaceuticals Latest Developments
Table 148. Neurotech Pharmaceuticals Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 149. Neurotech Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 150. Neurotech Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Neurotech Pharmaceuticals Main Business
Table 152. Neurotech Pharmaceuticals Latest Developments
Table 153. Teva Pharmaceutical Industries Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 154. Teva Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 155. Teva Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Teva Pharmaceutical Industries Main Business
Table 157. Teva Pharmaceutical Industries Latest Developments
Table 158. Sun Pharmaceutical Industries Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 159. Sun Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 160. Sun Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. Sun Pharmaceutical Industries Main Business
Table 162. Sun Pharmaceutical Industries Latest Developments
Table 163. EyeGate Pharmaceuticals Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 164. EyeGate Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 165. EyeGate Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. EyeGate Pharmaceuticals Main Business
Table 167. EyeGate Pharmaceuticals Latest Developments
Table 168. PolyActiva Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 169. PolyActiva Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 170. PolyActiva Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 171. PolyActiva Main Business
Table 172. PolyActiva Latest Developments
Table 173. EyeD Pharma Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 174. EyeD Pharma Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 175. EyeD Pharma Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 176. EyeD Pharma Main Business
Table 177. EyeD Pharma Latest Developments
Table 178. Ripple Therapeutics Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 179. Ripple Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 180. Ripple Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 181. Ripple Therapeutics Main Business
Table 182. Ripple Therapeutics Latest Developments
Table 183. Re?Vana Therapeutics Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 184. Re?Vana Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 185. Re?Vana Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 186. Re?Vana Therapeutics Main Business
Table 187. Re?Vana Therapeutics Latest Developments
Table 1. Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Subcutaneous and Intramuscular Implants
Table 4. Major Players of Intravitreal and Ocular Implants
Table 5. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type (2021-2026) & (K Units)
Table 6. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Type (2021-2026)
Table 7. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Type (2021-2026) & ($ million)
Table 8. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Type (2021-2026)
Table 9. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Oncology and Chronic Pain
Table 11. Major Players of Ophthalmology
Table 12. Major Players of Endocrine and Women's Health
Table 13. Major Players of Other
Table 14. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Disease (2021-2026) & (K Units)
Table 15. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Disease (2021-2026)
Table 16. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Disease (2021-2026) & ($ million)
Table 17. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Disease (2021-2026)
Table 18. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Disease (2021-2026) & (US$/Unit)
Table 19. Major Players of Biodegradable
Table 20. Major Players of Non-Degradable
Table 21. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Polymer Type (2021-2026) & (K Units)
Table 22. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Polymer Type (2021-2026)
Table 23. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Polymer Type (2021-2026) & ($ million)
Table 24. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Polymer Type (2021-2026)
Table 25. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Polymer Type (2021-2026) & (US$/Unit)
Table 26. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale by Application (2021-2026) & (K Units)
Table 27. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Market Share by Application (2021-2026)
Table 28. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Application (2021-2026) & ($ million)
Table 29. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Application (2021-2026)
Table 30. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Company (2021-2026) & (K Units)
Table 32. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Company (2021-2026)
Table 33. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Company (2021-2026)
Table 35. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Long-Acting Implant & Ocular Drug-Delivery Polymer System Producing Area Distribution and Sales Area
Table 37. Players Long-Acting Implant & Ocular Drug-Delivery Polymer System Products Offered
Table 38. Long-Acting Implant & Ocular Drug-Delivery Polymer System Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share Geographic Region (2021-2026)
Table 43. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Country/Region (2021-2026)
Table 47. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Country (2021-2026) & (K Units)
Table 50. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Country (2021-2026)
Table 51. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type (2021-2026) & (K Units)
Table 53. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Application (2021-2026) & (K Units)
Table 54. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Region (2021-2026) & (K Units)
Table 55. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Region (2021-2026)
Table 56. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type (2021-2026) & (K Units)
Table 58. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Application (2021-2026) & (K Units)
Table 59. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Country (2021-2026) & (K Units)
Table 60. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type (2021-2026) & (K Units)
Table 62. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Long-Acting Implant & Ocular Drug-Delivery Polymer System
Table 68. Key Market Challenges & Risks of Long-Acting Implant & Ocular Drug-Delivery Polymer System
Table 69. Key Industry Trends of Long-Acting Implant & Ocular Drug-Delivery Polymer System
Table 70. Long-Acting Implant & Ocular Drug-Delivery Polymer System Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Long-Acting Implant & Ocular Drug-Delivery Polymer System Distributors List
Table 73. Long-Acting Implant & Ocular Drug-Delivery Polymer System Customer List
Table 74. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Novartis Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 90. Novartis Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Alcon Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 94. Alcon Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 95. Alcon Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Alcon Main Business
Table 97. Alcon Latest Developments
Table 98. Johnson & Johnson Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 99. Johnson & Johnson Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 100. Johnson & Johnson Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Johnson & Johnson Main Business
Table 102. Johnson & Johnson Latest Developments
Table 103. Bausch + Lomb Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 104. Bausch + Lomb Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 105. Bausch + Lomb Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Bausch + Lomb Main Business
Table 107. Bausch + Lomb Latest Developments
Table 108. EyePoint Pharmaceuticals Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 109. EyePoint Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 110. EyePoint Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. EyePoint Pharmaceuticals Main Business
Table 112. EyePoint Pharmaceuticals Latest Developments
Table 113. Regeneron Pharmaceuticals Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 114. Regeneron Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 115. Regeneron Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Regeneron Pharmaceuticals Main Business
Table 117. Regeneron Pharmaceuticals Latest Developments
Table 118. Santen Pharmaceutical Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 119. Santen Pharmaceutical Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 120. Santen Pharmaceutical Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Santen Pharmaceutical Main Business
Table 122. Santen Pharmaceutical Latest Developments
Table 123. Allergan (AbbVie) Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 124. Allergan (AbbVie) Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 125. Allergan (AbbVie) Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Allergan (AbbVie) Main Business
Table 127. Allergan (AbbVie) Latest Developments
Table 128. Alimera Sciences Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 129. Alimera Sciences Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 130. Alimera Sciences Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Alimera Sciences Main Business
Table 132. Alimera Sciences Latest Developments
Table 133. Ocular Therapeutix Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 134. Ocular Therapeutix Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 135. Ocular Therapeutix Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Ocular Therapeutix Main Business
Table 137. Ocular Therapeutix Latest Developments
Table 138. Graybug Vision Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 139. Graybug Vision Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 140. Graybug Vision Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Graybug Vision Main Business
Table 142. Graybug Vision Latest Developments
Table 143. Aerie Pharmaceuticals Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 144. Aerie Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 145. Aerie Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. Aerie Pharmaceuticals Main Business
Table 147. Aerie Pharmaceuticals Latest Developments
Table 148. Neurotech Pharmaceuticals Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 149. Neurotech Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 150. Neurotech Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Neurotech Pharmaceuticals Main Business
Table 152. Neurotech Pharmaceuticals Latest Developments
Table 153. Teva Pharmaceutical Industries Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 154. Teva Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 155. Teva Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Teva Pharmaceutical Industries Main Business
Table 157. Teva Pharmaceutical Industries Latest Developments
Table 158. Sun Pharmaceutical Industries Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 159. Sun Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 160. Sun Pharmaceutical Industries Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. Sun Pharmaceutical Industries Main Business
Table 162. Sun Pharmaceutical Industries Latest Developments
Table 163. EyeGate Pharmaceuticals Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 164. EyeGate Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 165. EyeGate Pharmaceuticals Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. EyeGate Pharmaceuticals Main Business
Table 167. EyeGate Pharmaceuticals Latest Developments
Table 168. PolyActiva Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 169. PolyActiva Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 170. PolyActiva Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 171. PolyActiva Main Business
Table 172. PolyActiva Latest Developments
Table 173. EyeD Pharma Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 174. EyeD Pharma Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 175. EyeD Pharma Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 176. EyeD Pharma Main Business
Table 177. EyeD Pharma Latest Developments
Table 178. Ripple Therapeutics Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 179. Ripple Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 180. Ripple Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 181. Ripple Therapeutics Main Business
Table 182. Ripple Therapeutics Latest Developments
Table 183. Re?Vana Therapeutics Basic Information, Long-Acting Implant & Ocular Drug-Delivery Polymer System Manufacturing Base, Sales Area and Its Competitors
Table 184. Re?Vana Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Product Portfolios and Specifications
Table 185. Re?Vana Therapeutics Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 186. Re?Vana Therapeutics Main Business
Table 187. Re?Vana Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Long-Acting Implant & Ocular Drug-Delivery Polymer System
Figure 2. Long-Acting Implant & Ocular Drug-Delivery Polymer System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Country/Region (2025)
Figure 10. Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Subcutaneous and Intramuscular Implants
Figure 12. Product Picture of Intravitreal and Ocular Implants
Figure 13. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Type in 2026
Figure 14. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Oncology and Chronic Pain
Figure 16. Product Picture of Ophthalmology
Figure 17. Product Picture of Endocrine and Women's Health
Figure 18. Product Picture of Other
Figure 19. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Disease in 2026
Figure 20. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Disease (2021-2026)
Figure 21. Product Picture of Biodegradable
Figure 22. Product Picture of Non-Degradable
Figure 23. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Polymer Type in 2026
Figure 24. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Polymer Type (2021-2026)
Figure 25. Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumed in Hospital
Figure 26. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Market: Hospital (2021-2026) & (K Units)
Figure 27. Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumed in Dental Clinic
Figure 28. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Market: Dental Clinic (2021-2026) & (K Units)
Figure 29. Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumed in Other
Figure 30. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Market: Other (2021-2026) & (K Units)
Figure 31. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Market Share by Application (2025)
Figure 32. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Application in 2025
Figure 33. Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Company in 2025 (K Units)
Figure 34. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Company in 2025
Figure 35. Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Company in 2025 ($ millions)
Figure 36. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Company in 2025
Figure 37. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales 2021-2026 (K Units)
Figure 40. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue 2021-2026 ($ millions)
Figure 41. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales 2021-2026 (K Units)
Figure 42. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue 2021-2026 ($ millions)
Figure 43. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales 2021-2026 (K Units)
Figure 44. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue 2021-2026 ($ millions)
Figure 47. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Country in 2025
Figure 48. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Country (2021-2026)
Figure 49. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Type (2021-2026)
Figure 50. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Application (2021-2026)
Figure 51. United States Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Region in 2025
Figure 56. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Region (2021-2026)
Figure 57. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Type (2021-2026)
Figure 58. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Application (2021-2026)
Figure 59. China Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 63. India Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Country in 2025
Figure 67. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Country (2021-2026)
Figure 68. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Type (2021-2026)
Figure 69. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Application (2021-2026)
Figure 70. Germany Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 71. France Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Application (2021-2026)
Figure 78. Egypt Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Long-Acting Implant & Ocular Drug-Delivery Polymer System in 2026
Figure 84. Manufacturing Process Analysis of Long-Acting Implant & Ocular Drug-Delivery Polymer System
Figure 85. Industry Chain Structure of Long-Acting Implant & Ocular Drug-Delivery Polymer System
Figure 86. Channels of Distribution
Figure 87. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Forecast by Region (2027-2032)
Figure 88. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Long-Acting Implant & Ocular Drug-Delivery Polymer System
Figure 2. Long-Acting Implant & Ocular Drug-Delivery Polymer System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Country/Region (2025)
Figure 10. Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Subcutaneous and Intramuscular Implants
Figure 12. Product Picture of Intravitreal and Ocular Implants
Figure 13. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Type in 2026
Figure 14. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Oncology and Chronic Pain
Figure 16. Product Picture of Ophthalmology
Figure 17. Product Picture of Endocrine and Women's Health
Figure 18. Product Picture of Other
Figure 19. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Disease in 2026
Figure 20. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Disease (2021-2026)
Figure 21. Product Picture of Biodegradable
Figure 22. Product Picture of Non-Degradable
Figure 23. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Polymer Type in 2026
Figure 24. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Polymer Type (2021-2026)
Figure 25. Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumed in Hospital
Figure 26. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Market: Hospital (2021-2026) & (K Units)
Figure 27. Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumed in Dental Clinic
Figure 28. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Market: Dental Clinic (2021-2026) & (K Units)
Figure 29. Long-Acting Implant & Ocular Drug-Delivery Polymer System Consumed in Other
Figure 30. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Market: Other (2021-2026) & (K Units)
Figure 31. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sale Market Share by Application (2025)
Figure 32. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Application in 2025
Figure 33. Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales by Company in 2025 (K Units)
Figure 34. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Company in 2025
Figure 35. Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue by Company in 2025 ($ millions)
Figure 36. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Company in 2025
Figure 37. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales 2021-2026 (K Units)
Figure 40. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue 2021-2026 ($ millions)
Figure 41. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales 2021-2026 (K Units)
Figure 42. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue 2021-2026 ($ millions)
Figure 43. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales 2021-2026 (K Units)
Figure 44. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue 2021-2026 ($ millions)
Figure 47. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Country in 2025
Figure 48. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Country (2021-2026)
Figure 49. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Type (2021-2026)
Figure 50. Americas Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Application (2021-2026)
Figure 51. United States Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Region in 2025
Figure 56. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Region (2021-2026)
Figure 57. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Type (2021-2026)
Figure 58. APAC Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Application (2021-2026)
Figure 59. China Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 63. India Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Country in 2025
Figure 67. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share by Country (2021-2026)
Figure 68. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Type (2021-2026)
Figure 69. Europe Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Application (2021-2026)
Figure 70. Germany Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 71. France Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share by Application (2021-2026)
Figure 78. Egypt Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Long-Acting Implant & Ocular Drug-Delivery Polymer System in 2026
Figure 84. Manufacturing Process Analysis of Long-Acting Implant & Ocular Drug-Delivery Polymer System
Figure 85. Industry Chain Structure of Long-Acting Implant & Ocular Drug-Delivery Polymer System
Figure 86. Channels of Distribution
Figure 87. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Forecast by Region (2027-2032)
Figure 88. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Long-Acting Implant & Ocular Drug-Delivery Polymer System Revenue Market Share Forecast by Application (2027-2032)
